In GBM, these neural progenitor cells may be activated to migrate and interact with high-grade astrocytomas, release certain fatty-acid ethanolamide agonists to TRPV1, reduce glioma expansion, and prolong survival by stimulating tumour-supressed TRPV1. The gene discussed is TRPV1; the disease is neoplasm.